PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS

围产期缺氧:肾上腺皮质代谢适应

基本信息

  • 批准号:
    6832783
  • 负责人:
  • 金额:
    $ 20.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-01-01 至 2006-12-31
  • 项目状态:
    已结题

项目摘要

EXCEED THE SPACE PROVIDED. Hypoxia during the perinatal period and during early infancy is a significant cause of mortality and morbidity. Adrenocortical hormones are a vital component of the adaptation to hypoxic stress. Furthermore, neonatal hypoxic hyperlipidemia is a significant clinical entity, and changes in specific lipid metabolites alter adrenal function. The long-term objective of this proposal is to characterize the short and long-term consequences of perinatal hypoxia on the control of the hypothalamic-pituitary-adrenal (HPA) system and lipid metabolism in the rat. Specific Aims 1 and 2 will evaluate the effect of neonatal hypoxia on the control of the hypothalamic-pituitary-adrenal axis by evaluating intracellular and systemic controllers of steroidogenesis, the timing and mechanisms of the stress-hyporesponsive period (SHRP), and the negative feedback control of CRH and POMC expression and ACTH release. Specific Aim 3 will characterize the long-term sequellae of perinatal hypoxia by evaluating subsequent HPA responses to stimuli in the adult rat. Specific Aim 4 will more fully characterize neonatal hypoxic hyperlipidemia by analyzing the interaction of neonatal hypoxia and glucocorticoid therapy, and by performing metabolomic analysis. Neonatal hypoxia from birth is accomplished by exposing newborn rats (with their lactating dams) to a hypoxic environment. Perinatal hypoxia is accomplished by exposing late-gestational pregnant rats to hypoxia and allowing them to deliver in a hypoxic environment. Physiological, biochemical and molecular assessment of adrenocortical function is performed by ACTH injection in vivo, using dispersed cells, evaluating StAR and PBR expression, and measuring CBG and glucocorticoid clearance. Hypothalamic-pituitary function is assessed by measuring stress- and CRH-induced ACTH release, by evaluating feedback sensitivity, and by analyzing pituitary, hypothalamic, and hippocampal function and pertinent receptor/hormone expression. Metabolic function is assessed by analysis of hepatic enzyme activity, as well as complete metabolomic analysis of serum and hepatic lipids. Characterization of the hypothalamic-pituitary-adrenal and metabolic adaptations to perinatal hypoxia can lead to new diagnostic approaches and therapies to minimize morbidity and mortality. PERFORMANCE SITE ========================================Section End===========================================
超出所提供的空间。围产期和婴儿早期缺氧是死亡率和发病率的重要原因。肾上腺皮质激素是适应低氧应激的重要组成部分。此外,新生儿低氧性高脂血症是一个重要的临床实体,特定脂质代谢产物的变化会改变肾上腺功能。本建议的长期目标是表征围产期缺氧对大鼠下丘脑-垂体-肾上腺(HPA)系统和脂质代谢控制的短期和长期后果。具体目的1和2将评估新生儿缺氧对下丘脑-垂体-肾上腺轴控制的影响,通过评估类固醇生成的细胞内和全身控制,应激-低反应期(SHRP)的时间和机制,以及CRH和POMC表达和ACTH释放的负反馈控制。特异性目的3将通过评估成年大鼠随后的HPA对刺激的反应来表征围产期缺氧的长期后遗症。特异性Aim 4将通过分析新生儿缺氧与糖皮质激素治疗的相互作用,以及进行代谢组学分析,更全面地表征新生儿缺氧高脂血症。从出生开始的新生儿缺氧是通过将新生大鼠(及其泌乳坝)暴露在缺氧环境中来完成的。围产期缺氧是通过将妊娠晚期的怀孕大鼠暴露在缺氧环境中并让它们在缺氧环境中分娩来实现的。肾上腺皮质功能的生理、生化和分子评估是通过体内注射ACTH,使用分散细胞,评估StAR和PBR表达,测量CBG和糖皮质激素清除率。通过测量应激和crh诱导的ACTH释放、评估反馈敏感性、分析垂体、下丘脑和海马功能和相关受体/激素表达来评估下丘脑-垂体功能。代谢功能是通过分析肝酶活性,以及血清和肝脂的完整代谢组学分析来评估的。下丘脑-垂体-肾上腺和代谢对围产期缺氧的适应特征可以导致新的诊断方法和治疗,以减少发病率和死亡率。网站性能 ======================================== 节结束 ===========================================

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HERSHEL RAFF其他文献

HERSHEL RAFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HERSHEL RAFF', 18)}}的其他基金

PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
  • 批准号:
    2724093
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
  • 批准号:
    6580136
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
  • 批准号:
    6138085
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
  • 批准号:
    6342526
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
  • 批准号:
    6985329
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
  • 批准号:
    6489715
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
  • 批准号:
    6691701
  • 财政年份:
    1999
  • 资助金额:
    $ 20.46万
  • 项目类别:
ROLE OF OXYGEN IN ALDOSTERONOGENESIS
氧气在醛固酮生成中的作用
  • 批准号:
    3244945
  • 财政年份:
    1990
  • 资助金额:
    $ 20.46万
  • 项目类别:
ROLE OF OXYGEN IN ALDOSTERONOGENESIS
氧气在醛固酮生成中的作用
  • 批准号:
    3244944
  • 财政年份:
    1990
  • 资助金额:
    $ 20.46万
  • 项目类别:
ROLE OF OXYGEN IN ALDOSTERONOGENESIS
氧气在醛固酮生成中的作用
  • 批准号:
    3244941
  • 财政年份:
    1990
  • 资助金额:
    $ 20.46万
  • 项目类别:

相似海外基金

NSF PRFB FY 2023: Heritable phenotypes and mechanisms through transgenerational plasticity in response to hypoxia in fish
NSF PRFB 2023 财年:通过跨代可塑性响应鱼类缺氧的遗传表型和机制
  • 批准号:
    2305837
  • 财政年份:
    2024
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Fellowship Award
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
  • 批准号:
    23H02086
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of transcatheter arterial embolization for controlling hypoxia in hepatocellular carcinoma
经导管动脉栓塞控制肝细胞癌缺氧的研究进展
  • 批准号:
    23K07075
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Function, regulation, and conservation of hypoxia-induced glycolysis condensates
缺氧诱导的糖酵解缩合物的功能、调节和保存
  • 批准号:
    10552295
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
NSF-BSF: Mechanism of Cuticle Remodeling by Hypoxia
NSF-BSF:缺氧角质层重塑机制
  • 批准号:
    2308879
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Continuing Grant
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
  • 批准号:
    23K14987
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
  • 批准号:
    10578000
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
Intermittent Hypoxia Initiated Motor Plasticity in Individuals with Multiple Sclerosis
间歇性缺氧引发多发性硬化症患者的运动可塑性
  • 批准号:
    10593412
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
NSF/BIO-DFG: Cytochrome c oxidase adaptation to hypoxia in systemic vascular cells - From structure to function
NSF/BIO-DFG:细胞色素 c 氧化酶对全身血管细胞缺氧的适应 - 从结构到功能
  • 批准号:
    2329629
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Standard Grant
Acute intermittent hypoxia as a novel cardio-therapeutic for spinal cord injury
急性间歇性缺氧作为脊髓损伤的新型心脏治疗方法
  • 批准号:
    478667
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了